Beckman Coulter Diagnostics Demonstrates Solutions to Balance Better C…

Standardized Processes and Improved Operational Efficiency Move Healthcare Forward

---

BREA, CALIF. — (July 24, 2015) — Beckman Coulter Diagnostics will be showcasing its comprehensive portfolio of high-productivity analytical and workflow systems at the 2015 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga., July 28-30, 2015. Clinical Lab Expo attendees are invited to the Beckman Coulter booth to experience this year’s theme – “Balance Better Patient Care and Efficiency” – to learn how laboratories are achieving clinical, operational and financial goals by partnering with Beckman Coulter. Solutions featured in the booth (#2409) will include:

• The Power Express automation solution which can enable laboratories to handle the changing workflow and expanding needs of today’s clinical laboratory.
• The new DxH Connected Workcell which offers laboratories efficient workflow management while delivering comprehensive and accurate patient results.
• IRIS International urinalysis solutions, leading the industry in automated urinalysis.
• The MicroScan microbiology portfolio – including the MicroScan WalkAway plus – the customizable microbiology automation solution and latest addition to the Beckman Coulter portfolio. The MicroScan WalkAway plus microbiology system provides high-quality performance, efficiency for ID/AST testing and specimen processing that is scalable to meet varying laboratory needs.
• Clinical IT Solutions including the newly released version REMISOL Advance* enterprise data management system and hc1.com which are helping to manage laboratory workflow, standardize operations across hospital networks and increase productivity.

Booth visitors will experience how Beckman Coulter is helping laboratories balance better patient care and efficiency to achieve goals such as standardized processes to achieve increased capacity, and minimizing errors and reducing TAT to improve physician confidence.

“The American Association of Clinical Chemistry Annual Meeting allows us the opportunity to share with the diverse diagnostics laboratory industry how we partner to move healthcare forward,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “This year, we are particularly eager to share our newest product offerings and demonstrate to laboratories in a unique, interactive way, how with personalized, expert attention, clinical data management tools and the Danaher Business System, laboratories can to drive continuous improvement and sustainment in today’s healthcare landscape.”

Beckman Coulter Diagnostics will be offering a robust scientific program throughout the meeting, offering numerous industry-sponsored workshops, brown bag sessions, short courses and posters. Plus, attendees can stop by the booth to speak one-on-one with Beckman Coulter’s scientific experts.

Industry Sponsored Workshops:

From Operations to Innovation: Driving and Sustaining Change in the Laboratory
7 a.m. – 9 a.m. | Tuesday, July 28
A706-A707, Atlanta Marriott Marquis
Learn how focused change management and process improvement can be used to gain efficiencies and drive innovation and growth.

Contemporary Use of Troponin I: New Clinical Studies and Current Practice Guidelines
7 a.m. – 9 a.m. | Tuesday, July 28
Marquis Ballroom Salon C, Atlanta Marriott Marquis
This session is intended for laboratory personnel, pathologists and physicians involved with testing of markers for acute myocardial infarction, and with the interpretation of those values per established clinical guidelines.

Brown Bag Session:

Tuesday, July 28 |7:30 a.m. – 8:30 a.m. & 12:30 p.m. – 1:30 p.m.
The Laboratory and Sepsis: Current Definitions in Clinical Practice and Challenges Finding New Sepsis Biomarkers (43103/53203)
Fernando Chaves, M.D.

Wednesday, July 29 | 7:30 AM – 8:30 AM & 12:30 PM – 1:30 PM
HIV Testing: Epidemiology, Diagnosis and Laboratory Testing Recommendation (44121/54221)
Annette Adelmann, BA, MBA

Testing for Chronic Kidney Disease (CKD): Creatinine, GFR, UAlb and More: Industry Responses to Clinical Needs Developed in Cooperation with Industry Division (44123/54223)
Jack Zakowski, Ph.D., FACB

Anti-Müllerian Hormone (AMH): Ovarian Reserve and Beyond (44126/54226)
Lindsay Sun, M.D., MA.

Short Course:
Wednesday, July 29 | 2:30 p.m. – 5 p.m.

Troubleshooting Clinical Laboratory Errors: Collaborative Case Studies (74216)
Troubleshooting the Sources of Preanalytical Variability
Sol Green, Ph.D., FACB
BD Preanalytical Systems, Franklin Lakes, NJ

Troubleshooting and Eliminating Analytical Errors
Jack Zakowski, Ph.D., FACB
Beckman Coulter, Brea, CA

Investigating Unusual Results: Clinical Cases
Geoffry Baird, M.D., Ph.D.
University of Washington, Seattle, WA

Posters:
Serum Biomarkers and Obstructive Sleep Apnea (A-007)
Wesley Elon Fleming¹, Aliya Ferouz-Colborn², Michael K. Samoszuk³, Armaghan Azad¹,
Amabelle B. Cruz³, Susann Voyer Pololak¹, Kurtis R. Bray³, Paula C. Southwich³

1. Sleep Center Orange County, Irvine, CA
2. San Diego Sleep and Sinus Clinic, Encinitas, CA
3. Beckman Coulter, Inc., Brea, CA

Protype of Accurate and Precise Immunoassay for Low Estradiol Concentration Determination
McLernon, T.¹.; Romeu, E.²; Melchionno, P.²; Germain, N.²; Fonteneau, H.²

1. Beckman Coulter, Chaska, MN
2. Beckman Coulter, Marseille, France

A Prospective Multi-site Evaluation of the Intra-menstrual Cycle Variability of Anti-Müllerian Hormone (AMH) Using an Automated AMH Immunoassay
S. S. Shin¹, K. L. Jones², D. R. Holmes², L. G. Martin², K. L. Rossow², T. Her², J. S. Chamberlin¹, L. R. Lofaro¹, D. L. Broyles¹

1. Beckman Coulter, Inc., Carlsbad, CA
2. Beckman Coulter, Chaska, MN

DxH PROService Solutions: A Case Study – Proactive Monitoring of System Data
J. Colom, C. Ramirez, J. Lu, J. Castillo, S. Guntupalli, P. O’Neil
Beckman Coulter, Miami, FL

Characteristics of the New Beckman Coulter Thyroid Stimulating Hormone Assay (TSH(3rd IS)) (A-113)
Benjamin Dumke, Fete (Peter) Krohn, Craig Lundeen, Kim Paulsen, Lukas Radde,
Medin Shukarey, Miklos Szabo and Wynette Dietz
Beckman Coulter, Chaska, MN

Characteristics of the New Beckman Coulter High-Sensitive Cardiac Troponin I Assay (hsTnI)
Dorothy Arockiasamy, Elisha Cicirelli, Jill Granger,
Miklos Szabo and Molly Thomas
Beckman Coulter, Chaska, MN

Analytical Performances and Method Comparison Studies of the Beckman Coulter Access 25(OH) Vitamin D Total Assay (A-073)
Tehranchi, J; Cusseme, C; Bonjean, S; Michaud, L; Solari, M; Romeu, E; Villeneuve, S
Beckman Coulter, Chaska, MN

Evaluation of a New Urinary and CSF Albumin Assay on the Beckman Coulter AU5800 Clinical Chemistry System
Ben Godber¹, Hans Parsch², Astrid Schmid², Reimund Haas², Richard FitzGerald¹, Joann Reynolds¹, Sheri Jordan³

1. Beckman Coulter Ireland, Co. Clare, Ireland
2. Zentrallabor des Universitätsklinikums, Erlangen, Germany
3. Beckman Coulter, Brea, CA, USA

Automated Sample Preparation for the Monitoring of Pharmaceutical Drug Diversion by LC-MS/MS
M. J. Y. Jarvis¹, L. Sharma², M. Kowalski³, A. Gibson³, N. Quach³

1. SCIEX, Concord, ON, Canada
2. Vision Laboratories, Chattanooga, TN
3. Beckman Coulter Life Sciences, Indianapolis, IN

About Beckman Coulter
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For 80 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes, offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, microbiology, automation and information systems. Beckman Coulter is dedicated to advancing healthcare for every person and moving science, innovation and the lab forward. For more information, visit www.beckmancoulter.com.